title: Are medication-free periods necessary for phase 3 trials of new antipsychotic drugs?
authors.forename: J
authors.initials: J
authors.lastname: Volavka
mesh_terms: D000818:Animals; D014150:Antipsychotic Agents / Q000627:therapeutic use*; D017326:Clinical Trials, Phase III as Topic / Q000379:methods* / Q000592:standards; D004311:Double-Blind Method; D004334:Drug Administration Schedule; D015507:Drugs, Investigational / Q000627:therapeutic use; D006801:Humans; D010919:Placebos; D051381:Rats; D012008:Recurrence; D012107:Research Design / Q000592:standards
chemical_list: D014150:Antipsychotic Agents; D015507:Drugs, Investigational; D010919:Placebos